Browsing: Wellness Tips

[Sportschosun Cho Yoon-sun] Stylist Han Hye-yeon drew attention after revealing her slim back view following a 16kg weight loss

As the use of glucagon-like peptide-1 (GLP-1) class obesity treatments such as Wegovy and Mounjaro increases, reports of side effects are drawing attention. A wide range of issues is being reported, from the well-known gastrointestinal problems to hair loss

A recent study published in Cancer Communications has found that obesity may be responsible for more than 11% of cancer cases, challenging earlier estimates that placed the figure at around 5.5%

Novo Nordisk announced Friday that it has asked a U.S. court to issue a preliminary injunction halting a series of obesity and diabetes drug advertisements run by Eli Lilly, marking a new front in the two companies’ legal confrontation over weight loss treatments

For decades, Italy symbolised healthy eating. Fresh vegetables, olive oil, whole grains, legumes and fish made the Mediterranean diet famous across the globe. But a recent BBC report tells a very different story.In southern Italy’s Campania region, more than 40% of eight- and nine-year-old children are overweight, making it one of Europe’s worst-affected areas. The…

[Sportschosun reporter Jung Yoo-na] Ok-soon from the 22nd season of “I Am Solo” shared striking before-and-after photos after giving birth and revealed her own weight-management secret

Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge

Kroger is using its nationwide footprint and health division to offer more integrated services around weight management, an area drawing heightened consumer and medical attention. The GLP-1 Complete Support Program ties pharmacy, nutrition, and clinical support together, which may matter to customers seeking more structure around GLP-1 use. For investors tracking NYSE:KR, it highlights how…

Primary Biliary Cholangitis (PBC) Diet Guide Search AdvertisementAdvertisement July 22, 2026/Health Conditions/Digestive

Retatrutide just took a major step in its journey toward FDA approval. Eli Lilly, the company that makes retatrutide, announced the topline results from its TRIUMPH clinical trial program